Información del artículo
Resumen
El carcinoma de células renales es la octava neoplasia maligna más frecuente en el adulto y la más frecuente del riñón. Es, por tanto, una enfermedad muy común para el radiólogo. El objetivo de esta revisión es hacer una aproximación general a las diferentes técnicas de imagen utilizadas para diagnosticar, caracterizar y ayudar a planificar el tratamiento del carcinoma de células renales, así como hacer consideraciones básicas sobre la estadificación, el tratamiento percutáneo guiado con técnicas de imagen y el seguimiento en las situaciones clínicas más habituales.
Palabras clave:
Neoplasias renales
Cáncer renal
Carcinoma de células renales
Estadificación neoplasia
Diagnóstico por la imagen
Abstract
Renal cell carcinoma is the eighth most common malignancy in adults and the most common malignancy in the kidney. It is thus a very common disease for radiologists. This review aims to provide a general overview of the imaging techniques used to diagnose, characterize, and help plan the treatment of renal cell carcinoma as well as to review basic aspects related to staging, imaging-guided percutaneous treatment, and follow-up in the most common clinical scenarios.
Keywords:
Renal tumors
Kidney cancer
Renal cell carcinoma
Tumor staging
Diagnostic imaging
Artículo
Opciones para acceder a los textos completos de la publicación Radiología
Suscriptor
Comprar
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M.J. Thun.
Cancer statistics. 2007.
CA Cancer J Clin, 57 (2007), pp. 43-66
[2]
C.S. Ng, C.G. Wood, P.M. Silverman, N.M. Tannir, P. Tamboli, C.M. Sandler.
Renal cell carcinoma: Diagnosis, staging, and surveillance.
AJR Am J Roentgenol, 191 (2008), pp. 1220-1232
[3]
V.E. Reuter.
The pathology of renal epithelial neoplasms.
Semin Oncol, 33 (2006), pp. 534-543
[4]
M.R. Sun, L. Ngo, E.M. Genega, M.B. Atkins, M.E. Finn, N.M. Rofsky, et al.
Renal cell carcinoma: Dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes−correlation with pathologic findings.
Radiology, 250 (2009), pp. 793-802
[5]
S.R. Prasad, P.A. Humphrey, J.R. Catena, V.R. Narra, J.R. Srigley, A.D. Cortez, et al.
Common and uncommon histologic subtypes of renal cell carcinoma: Imaging spectrum with pathologic correlation.
Radiographics, 26 (2006), pp. 1795-1806
[6]
J. Verine, A. Pluvinage, G. Bousquet, J. Lehmann-Che, C. de Bazelaire, N. Soufir, et al.
Hereditary renal cancer syndromes: An update of a systematic review.
Eur Urol, 58 (2010), pp. 701-710
[7]
W.H. Chow, S.S. Devesa, J.L. Warren, J.F. Fraumeni.
Rising incidence of renal cell cancer in the United States.
JAMA, 281 (1999), pp. 1628-1631
[8]
S.N. Chawla, P.L. Crispen, A.L. Hanlon, R.E. Greenberg, D.Y.T. Chen, R.G. Uzzo.
The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature.
J Urol, 175 (2006), pp. 425-431
[9]
M. Jayson, H. Sanders.
Increased incidence of serendipitously discovered renal cell carcinoma.
Urology, 51 (1998), pp. 203-205
[10]
L.G. Luciani, R. Cestari, C. Tallarigo.
Incidental renal cell carcinoma-age and stage characterization and clinical implications: Study of 1092 patients (1982-1997).
Urology, 56 (2000), pp. 58-62
[11]
I. Frank, M.L. Blute, J.C. Cheville, C.M. Lohse, A.L. Weaver, H. Zincke.
Solid renal tumors: An analysis of pathological features related to tumor size.
J Urol, 170 (2003), pp. 2217-2220
[12]
U. Patel, H. Sokhi.
Imaging in the follow-up of renal cell carcinoma.
AJR Am J Roentgenol, 198 (2012), pp. 1266-1276
[13]
S.R. Prasad, N.C. Dalrymple, V.R. Surabhi.
Cross-sectional imaging evaluation of renal masses.
Radiol Clin North Am, 46 (2008), pp. 95-111
[14]
L. Pallwein-Prettner, D. Flöry, C.R. Rotter, K. Pogner, G. Syré, C. Fellner, et al.
Assessment and characterisation of common renal masses with CT and MRI.
Insights Imaging, 2 (2011), pp. 543-556
[15]
I. Pedrosa, D.C. Alsop, N.M. Rofsky.
Magnetic resonance imaging as a biomarker in renal cell carcinoma.
Cancer, 115 (2009), pp. 2334-2345
[16]
C. Nicolau, L. Bunesch, C. Sebastia.
Renal complex cysts in adults: Contrast-enhanced ultrasound.
Abdom lmaging, 36 (2011), pp. 742-752
[17]
Curry NS, Francis IR, Casalino DD, Arellano RS, Baumgarten DA, Dighe M, et al. ACR Appropriateness Criteria® renal cell carcinoma staging [acceso 3 Ene 2013]. Disponible en: http://guideline.gov/content.aspx?id=35153
[18]
B.F. Chapin, S.E. Delacroix, C.G. Wood.
Renal cell carcinoma: What the surgeon and treating physician need to know.
AJR Am J Roentgenol, 196 (2011), pp. 1255-1262
[19]
T. Ozülker, F. Ozülker, E. Ozbek, T. Ozpaçaci.
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Nucl Med Commun, 32 (2011), pp. 265-272
[20]
R.D. Brierly, P.J. Thomas, N.W. Harrison, M.S. Fletcher, J.D. Nawrocki, M. Ashton-Key.
Evaluation of fine-needle aspiration cytology for renal masses.
BJU Int, 85 (2000), pp. 14-18
[21]
B.R. Herts, M.E. Baker.
The current role of percutaneous biopsy in the evaluation of renal masses.
Semin Urol Oncol, 13 (1995), pp. 254-261
[22]
B.M. Benway, S.B. Bhayani.
Approach to the small renal mass: Weighing treatment options.
Curr Urol Rep, 10 (2009), pp. 11-16
[23]
S.G. Silverman, Y.U. Gan, K.J. Mortele, K. Tuncali, E.S. Cibas.
Renal masses in the adult patient: The role of percutaneous biopsy.
Radiology, 240 (2006), pp. 6-22
[24]
O. Stakhovsky, R. Sánchez-Salas, E. Barret, S.A. Yap, A. Finelli, F. Rozet, et al.
Renal biopsies for small renal masses. For whom, when and how.
Arch Esp Urol, 66 (2013), pp. 4-15
[25]
B.I. Yuh, R.H. Cohan.
Different phases of renal enhancement: Role in detecting and characterizing renal masses during helical CT.
AJR Am J Roentgenol, 173 (1999), pp. 747-755
[26]
D.H. Szolar, F. Kammerhuber, S. Altziebler, M. Tillich, E. Breinl, R. Fotter, et al.
Multiphasic helical CT of the kidney: Increased conspicuity for detection and characterization of small (<3cm) renal masses.
Radiology, 202 (1997), pp. 211-217
[27]
P.T. Johnson, K.M. Horton, E.K. Fishman.
How not to miss or mischaracterize a renal cell carcinoma: Protocols, pearls, and pitfalls.
AJR Am J Roentgenol, 194 (2010), pp. W307-W315
[28]
H. Wang, L. Cheng, X. Zhang, D. Wang, A. Guo, Y. Gao, et al.
Renal cell carcinoma: Diffusion-weighted MR imaging for subtype differentiation at 3.0T.
Radiology, 257 (2010), pp. 135-143
[29]
I. Pedrosa, M.R. Sun, M. Spencer, E.M. Genega, A.F. Olumi, W.C. Dewolf, et al.
MR imaging of renal masses: Correlation with findings at surgery and pathologic analysis.
Radiographics, 28 (2008), pp. 985-1003
[30]
G.M. Israel, M.A. Bosniak.
How I do it: Evaluating renal masses.
Radiology, 236 (2005), pp. 441-450
[31]
D.S. Hartman, C.J. Davis, T. Johns, S.M. Goldman.
Cystic renal cell carcinoma.
Urology, 28 (1986), pp. 145-153
[32]
M.A. Bosniak.
The current radiological approach to renal cysts.
Radiology, 158 (1986), pp. 1-10
[33]
M.A. Bosniak.
The use of the Bosniak classification system for renal cysts and cystic tumors.
J Urol, 157 (1997), pp. 1852-1853
[34]
G.M. Israel, N. Hindman, M.A. Bosniak.
Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system.
Radiology, 231 (2004), pp. 365-371
[35]
I. Millet, F.C. Doyon, D. Hoa, R. Thuret, S. Merigeaud, I. Serre, et al.
Characterization of small solid renal lesions: Can benign and malignant tumors be differentiated with CT?.
AJR Am J Roentgenol, 197 (2011), pp. 887-896
[36]
S.G. Silverman, G.M. Israel, B.R. Herts, J.P. Richie.
Management of the incidental renal mass.
Radiology, 249 (2008), pp. 16-31
[37]
M.A. Bosniak, A.J. Megibow, D.H. Hulnick, S. Horii, B.N. Raghavendra.
CT diagnosis of renal angiomyolipoma: The importance of detecting small amounts of fat.
AJR Am J Roentgenol, 151 (1988), pp. 497-501
[38]
H.T. Cohen, F.J. McGovern.
Renal-cell carcinoma.
N Engl J Med, 353 (2005), pp. 2477-2490
[39]
A. Lesavre, J.M. Correas, S. Merran, N. Grenier, A. Vieillefond, O. Hélénon.
CT of papillary renal cell carcinomas with cholesterol necrosis mimicking angiomyolipomas.
AJR Am J Roentgenol, 181 (2003), pp. 143-145
[40]
T.J. Polascik, D.G. Bostwick, P. Cairns.
Molecular genetics and histopathologic features of adult distal nephron tumors.
Urology, 60 (2002), pp. 941-946
[41]
S.R. Prasad, P.A. Humphrey, C.O. Menias, W.D. Middleton, M.J. Siegel, K.T. Bae, et al.
Neoplasms of the renal medulla: Radiologic-pathologic correlation.
Radiographics, 25 (2005), pp. 369-380
[42]
V.A. Sahni, M.S. Hirsch, C.A. Sadow, S.G. Silverman.
Mucinous tubular and spindle cell carcinoma of the kidney: Imaging features.
Cancer Imaging, 12 (2012), pp. 66-71
[43]
A. Prando, D. Prando, P. Prando.
Renal cell carcinoma: Unusual imaging manifestations.
Radiographics, 26 (2006), pp. 233-245
[44]
AJCC Cancer Staging Manual, 7th ed., pp. 479-486
[45]
B. Ljungberg, N.C. Cowan, D.C. Hanbury, M. Hora, M.A. Kuczyk, A.S. Merseburger, et al.
EAU guidelines on renal cell carcinoma: The 2010 update.
Eur Urol, 58 (2010), pp. 398-406
[46]
A.M. Venkatesan, B.J. Wood, D.A. Gervais.
Percutaneous ablation in the kidney.
Radiology, 261 (2011), pp. 375-391
[47]
V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. de Caro, et al.
Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery.
Eur Urol, 56 (2009), pp. 786-793
[48]
A. Kutikov, R.G. Uzzo.
The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth.
J Urol, 182 (2009), pp. 844-853
[49]
M.N. Simmons, C.B. Ching, M.K. Samplaski, C.H. Park, I.S. Gill.
Kidney tumor location measurement using the C index method.
J Urol, 183 (2010), pp. 1708-1713
[50]
T.J. Guzzo, P.M. Pierorazio, E.M. Schaeffer, E.K. Fishman, M.E. Allaf.
The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma.
J Urol, 181 (2009), pp. 486-490
[51]
K. Ito, H. Nakazawa, K. Marumo, S. Ozono, T. Igarashi, N. Shinohara, et al.
Risk factors for ipsilateral adrenal involvement in renal cell carcinoma.
Urology, 72 (2008), pp. 354-358
[52]
C. Catalano, F. Fraioli, A. Laghi, A. Napoli, F. Pediconi, M. Danti, et al.
High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma.
AJR Am J Roentgenol, 180 (2003), pp. 1271-1277
[53]
I.R. Francis.
Detection, staging and surveillance in renal cell carcinoma.
Cancer Imaging, 6 (2006), pp. 168-174
[54]
A.B. Fein, J.K. Lee, D.M. Balfe, J.P. Heiken, D. Ling, H.S. Glazer, et al.
Diagnosis and staging of renal cell carcinoma: A comparison of MR imaging and CT.
AJR Am J Roentgenol, 148 (1987), pp. 749-753
[55]
C.D. Johnson, N.R. Dunnick, R.H. Cohan, F.F. Illescas.
Renal adenocarcinoma: CT staging of 100 tumors.
AJR Am J Roentgenol, 148 (1987), pp. 59-63
[56]
N. Griffin, M.E. Gore, S.A. Sohaib.
Imaging in metastatic renal cell carcinoma.
AJR Am J Roentgenol, 189 (2007), pp. 360-370
[57]
B.P. Butler, A.C. Novick, D.P. Miller, S.A. Campbell, M.R. Licht.
Management of small unilateral renal cell carcinomas: Radical versus nephron-sparing surgery.
Urology, 45 (1995), pp. 34-40
[58]
L.J. Zurera, D. López, M. Canis, J. García-Revillo, P. Campos, R. Robles, et al.
Radiofrequency ablation of renal tumors: Practical aspects and results.
Radiología, 52 (2010), pp. 228-233
[59]
A. Pirasteh, L. Snyder, N. Boncher, M. Passalacqua, D. Rosenblum, J.D. Prologo.
Cryoablation vs. radiofrequency ablation for small renal masses.
Acad Radiol, 18 (2011), pp. 97-100
[60]
X. Buy, H. Lang, J. Garnon, A. Gangi.
Percutaneous ablation of renal tumors: Radiofrequency ablation or cryoablation?.
J Radiol, 92 (2011), pp. 774-788
[61]
B.C. Allen, E.M. Remer.
Percutaneouscryoablation of renal tumors: Patient selection, technique, and postprocedural imaging.
Radiographics, 30 (2010), pp. 887-900
[62]
S.N. Goldberg, C.J. Grassi, J.F. Cardella, J.W. Charboneau, G.D. Dodd, D.E. Dupuy, et al.
Image-guided tumor ablation: Standardization of terminology and reporting criteria.
Radiology, 235 (2005), pp. 728-739
[63]
V. Sundaram, R.S. Figenshau, T.M. Roytman, A.S. Kibel, R.L. Grubb, A. Bullock, et al.
Positive margin during partial nephrectomy: Does cancer remain in the renal remnant?.
Urology, 77 (2011), pp. 1400-1403
[64]
T. Klatte, J.S. Lam, B. Shuch, A.S. Belldegrun, A.J. Pantuck.
Surveillance for renal cell carcinoma: Why and how? When and how often?.
Urol Oncol, 26 (2008), pp. 550-554
[65]
A.B. Thumar, E.J. Trabulsi, C.D. Lallas, D.B. Brown.
Thermal ablation of renal cell carcinoma: Triage, treatment, and follow-up.
J Vasc Interv Radiol, 21 (2010), pp. S233-S241
[66]
R.J. Zagoria, J.A. Pettus, M. Rogers, D.M. Werle, D. Childs, J.R. Leyendecker.
Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma.
Urology, 77 (2011), pp. 1393-1397
[67]
S.F. Matin, K. Ahrar, J.A. Cadeddu, D.A. Gervais, F.J. McGovern, R.J. Zagoria, et al.
Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study.
J Urol, 176 (2006), pp. 1973-1977
[68]
P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, L. Rubinstein, et al.
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
J Natl Cancer Inst, 92 (2000), pp. 205-216
[69]
A.A. Van der Veldt, R.R. Meijerink, A.J. van der Eertwegh, J.B. Haanen, W. Boven.
Choi response criteria for early prediction of clinical outcome in patient with metastatic renal cell cancer treated with sunitinib.
Br J Cancer, 102 (2010), pp. 803-809
[70]
A.D. Smith, S.N. Shah, B.I. Rini, M.L. Lieber, E.M. Remer.
Morphology, Attenuation, Size, and Structure (MASS) criteria: Assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.
AJR Am J Roentgenol, 194 (2010), pp. 1470-1478
[71]
R. Thiam, L.S. Fournier, L. Trinquart, J. Medioni, G. Chatellier, D. Balvay, et al.
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib.
Ann Oncol, 21 (2010), pp. 936-941
[72]
K.M. Krajewski, M. Guo, A.D. van den Abbeele, J. Yap, N. Ramaiya, J. Jagannathan, et al.
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell ca.
Eur Urol, 59 (2011), pp. 856-862
[73]
P.D. Nathan, A. Vinayan, D. Stott, J. Juttla, V. Goh.
CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cell patients treated with targeted therapies.
Cancer Biol Ther, 1 (2010), pp. 15-19
